Estimation of long‐term survival with tafasitamab + lenalidomide (LEN) in relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) Meeting Abstract
| Authors: | Salles, G.; Goswami, B.; Bagnardi, V.; Dey, D.; Winderlich, M.; Ambarkhane, S.; Huang, D.; Nowakowski, G. S. |
| Abstract Title: | Estimation of long‐term survival with tafasitamab + lenalidomide (LEN) in relapsed/refractory diffuse large B‐cell lymphoma (R/R DLBCL) |
| Meeting Title: | 16th International Conference on Malignant Lymphoma - Virtual Edition |
| Journal Title: | Hematological Oncology |
| Volume: | 39 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Jun 18-22 |
| Meeting Location: | Virtual |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2021-06-01 |
| Start Page: | 254 |
| End Page: | 256 |
| Language: | English |
| ACCESSION: | 150947698 |
| DOI: | 10.1002/hon.90_2880 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| PUBMED: | 34105791 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 178 -- Accession Number: 150947698 -- Entry Date: In Process -- Revision Date: 20210618 -- Publication Type: Article -- Supplement Title: Jun2021 Supplement S2 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: Cinahl |
